Table 9.

Recommended Surveillance for Individuals with COL1A1/2 Osteogenesis Imperfecta

System/ConcernEvaluationFrequency
Musculoskeletal Orthopedic evaluationEvery 3 mos until age 1 yr, every 6 mos from 1 to 3 yrs, then annually or w/any new fractures
Physical & rehabilitation medicineAnnually or more frequently if necessary for more severe clinical forms
Physical therapyIn infancy for individuals w/motor delays & as needed to improve mobility & function
Neurologic CT &/or MRI examination w/views across base of skull to evaluate for basilar impressionIf concerning signs or symptoms are present 1
Cervical spine flexion & extension radiographsIn children able to cooperate w/examination or before participating in sporting activities in more mildly affected individuals
Dental Dental examinations2x/yr for those w/DI or at risk for DI
Audiologic Hearing evaluationEvery 3-5 yrs from age 5 yrs until HL is identified, then as indicated based on nature & degree of HL & associated interventions

DI = dentinogenesis imperfecta; HL = hearing loss

1.

There is no universal agreement on when screening for basilar impression should be performed.

From: COL1A1/2 Osteogenesis Imperfecta

Cover of GeneReviews®
GeneReviews® [Internet].
Adam MP, Feldman J, Mirzaa GM, et al., editors.
Seattle (WA): University of Washington, Seattle; 1993-2024.
Copyright © 1993-2024, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.

GeneReviews® chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (http://www.genereviews.org/) and copyright (© 1993-2024 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the GeneReviews® Copyright Notice and Usage Disclaimer. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.

For more information, see the GeneReviews® Copyright Notice and Usage Disclaimer.

For questions regarding permissions or whether a specified use is allowed, contact: ude.wu@tssamda.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.